Literature DB >> 12644500

The Moraxella catarrhalis immunoglobulin D-binding protein MID has conserved sequences and is regulated by a mechanism corresponding to phase variation.

Andrea Möllenkvist1, Therése Nordström, Christer Halldén, Jens Jørgen Christensen, Arne Forsgren, Kristian Riesbeck.   

Abstract

The prevalence of the Moraxella catarrhalis immunoglobulin D (IgD)-binding outer membrane protein MID and its gene was determined in 91 clinical isolates and in 7 culture collection strains. Eighty-four percent of the clinical Moraxella strains expressed MID-dependent IgD binding. The mid gene was detected in all strains as revealed by homology of the signal peptide sequence and a conserved area in the 3' end of the gene. When MID proteins from five different strains were compared, an identity of 65.3 to 85.0% and a similarity of 71.2 to 89.1% were detected. Gene analyses showed several amino acid repeat motifs in the open reading frames, and MID could be called a putative autotransport protein. Interestingly, homopolymeric [polyguanine [poly(G)]] tracts were detected at the 5' ends within the open reading frames. By flow cytometry, using human IgD and fluorescein isothiocyanate-conjugated anti-IgD polyclonal antibodies, most strains showed two peaks: one high- and one low-intensity peak. All isolates expressing high levels of MID had 1, 2, or 3 triplets of G's in their poly(G) tracts, while strains not expressing MID had 4, 7, 8, or 10 G's in their poly(G) tracts or point mutations causing a putative preterminated translation. Northern blot analysis revealed that the mid gene was regulated at the transcriptional level. Experiments with nonclumping variants of M. catarrhalis proved that bacteria lost their MID expression by removing a G in their poly(G) tracts. Moraxella strains isolated from the nasopharynx or from blood and sputum specimens expressed MID at approximately the same frequency. In addition, no variation was observed between strains of different geographical origins (Australia, Europe, Japan, or the United States). MID and the mid gene were found solely in M. catarrhalis, whereas related Neisseria and Moraxella species did not express MID. Taken together, MID appears to be a conserved protein that can be found in essentially all M. catarrhalis strains. Furthermore, MID is governed by poly(G) tracts when bacteria undergo phase variation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12644500      PMCID: PMC151486          DOI: 10.1128/JB.185.7.2285-2295.2003

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  53 in total

Review 1.  The great escape: structure and function of the autotransporter proteins.

Authors:  I R Henderson; F Navarro-Garcia; J P Nataro
Journal:  Trends Microbiol       Date:  1998-09       Impact factor: 17.079

2.  Outer-membrane antigen expression by Moraxella (Branhamella) catarrhalis influences pulmonary clearance.

Authors:  J M Kyd; A W Cripps; T F Murphy
Journal:  J Med Microbiol       Date:  1998-02       Impact factor: 2.472

Review 3.  Molecular and structural aspects of fimbriae biosynthesis and assembly in Escherichia coli.

Authors:  O Mol; B Oudega
Journal:  FEMS Microbiol Rev       Date:  1996-10       Impact factor: 16.408

4.  Characterization of the Moraxella catarrhalis uspA1 and uspA2 genes and their encoded products.

Authors:  L D Cope; E R Lafontaine; C A Slaughter; C A Hasemann; C Aebi; F W Henderson; G H McCracken; E J Hansen
Journal:  J Bacteriol       Date:  1999-07       Impact factor: 3.490

5.  Phase variation of HpuAB and HmbR, two distinct haemoglobin receptors of Neisseria meningitidis DNM2.

Authors:  L A Lewis; M Gipson; K Hartman; T Ownbey; J Vaughn; D W Dyer
Journal:  Mol Microbiol       Date:  1999-06       Impact factor: 3.501

6.  Effects on the ciliated epithelium of protein D-producing and -nonproducing nontypeable Haemophilus influenzae in nasopharyngeal tissue cultures.

Authors:  H Janson; B Carl n; A Cervin; A Forsgren; A B Magnusdottir; S Lindberg; T Runer
Journal:  J Infect Dis       Date:  1999-09       Impact factor: 5.226

7.  Analysis of the immunological responses to transferrin and lactoferrin receptor proteins from Moraxella catarrhalis.

Authors:  R H Yu; R A Bonnah; S Ainsworth; A B Schryvers
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

8.  The levels and bactericidal capacity of antibodies directed against the UspA1 and UspA2 outer membrane proteins of Moraxella (Branhamella) catarrhalis in adults and children.

Authors:  D Chen; V Barniak; K R VanDerMeid; J C McMichael
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

9.  The transferrin binding protein B of Moraxella catarrhalis elicits bactericidal antibodies and is a potential vaccine antigen.

Authors:  L E Myers; Y P Yang; R P Du; Q Wang; R E Harkness; A B Schryvers; M H Klein; S M Loosmore
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

10.  Enhancement of pulmonary clearance of Moraxella (Branhamella) catarrhalis following immunization with outer membrane protein CD in a mouse model.

Authors:  T F Murphy; J M Kyd; A John; C Kirkham; A W Cripps
Journal:  J Infect Dis       Date:  1998-12       Impact factor: 5.226

View more
  34 in total

1.  Genome analysis of Moraxella catarrhalis strain BBH18, [corrected] a human respiratory tract pathogen.

Authors:  Stefan P W de Vries; Sacha A F T van Hijum; Wolfgang Schueler; Kristian Riesbeck; John P Hays; Peter W M Hermans; Hester J Bootsma
Journal:  J Bacteriol       Date:  2010-05-07       Impact factor: 3.490

2.  The immunoglobulin D-binding protein MID from Moraxella catarrhalis is also an adhesin.

Authors:  Arne Forsgren; Marta Brant; Mirela Karamehmedovic; Kristian Riesbeck
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

3.  A UspA2H-negative variant of Moraxella catarrhalis strain O46E has a deletion in a homopolymeric nucleotide repeat common to uspA2H genes.

Authors:  Wei Wang; Melanie M Pearson; Ahmed S Attia; Robert J Blick; Eric J Hansen
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

4.  A Moraxella catarrhalis two-component signal transduction system necessary for growth in liquid media affects production of two lysozyme inhibitors.

Authors:  Stephanie N Joslin; Christine Pybus; Maria Labandeira-Rey; Amanda S Evans; Ahmed S Attia; Chad A Brautigam; Eric J Hansen
Journal:  Infect Immun       Date:  2014-10-13       Impact factor: 3.441

5.  Moraxella catarrhalis outer membrane vesicles carry β-lactamase and promote survival of Streptococcus pneumoniae and Haemophilus influenzae by inactivating amoxicillin.

Authors:  Viveka Schaar; Therése Nordström; Matthias Mörgelin; Kristian Riesbeck
Journal:  Antimicrob Agents Chemother       Date:  2011-05-16       Impact factor: 5.191

6.  Hag directly mediates the adherence of Moraxella catarrhalis to human middle ear cells.

Authors:  Brian Bullard; Serena L Lipski; Eric R Lafontaine
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

7.  Moraxella catarrhalis strain O35E expresses two filamentous hemagglutinin-like proteins that mediate adherence to human epithelial cells.

Authors:  Rachel Balder; Jonathan Hassel; Serena Lipski; Eric R Lafontaine
Journal:  Infect Immun       Date:  2007-03-19       Impact factor: 3.441

8.  The Hag protein of Moraxella catarrhalis strain O35E is associated with adherence to human lung and middle ear cells.

Authors:  Melissa M Holm; Serena L Vanlerberg; Darren D Sledjeski; Eric R Lafontaine
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

9.  Genome sequence of Moraxella catarrhalis RH4, an isolate of seroresistant lineage.

Authors:  Aldert Zomer; Stefan P W de Vries; Kristian Riesbeck; Andreas L Meinke; Peter W M Hermans; Hester J Bootsma
Journal:  J Bacteriol       Date:  2012-12       Impact factor: 3.490

10.  B cell activation by outer membrane vesicles--a novel virulence mechanism.

Authors:  Maria Laura A Perez Vidakovics; Johan Jendholm; Matthias Mörgelin; Anne Månsson; Christer Larsson; Lars-Olaf Cardell; Kristian Riesbeck
Journal:  PLoS Pathog       Date:  2010-01-15       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.